Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to -$1.8 million.

  • Rockwell Medical's Income from Continuing Operations fell 20901.44% to -$1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.7 million, marking a year-over-year decrease of 31210.37%. This contributed to the annual value of -$554000.0 for FY2024, which is 9367.58% up from last year.
  • Latest data reveals that Rockwell Medical reported Income from Continuing Operations of -$1.8 million as of Q3 2025, which was down 20901.44% from -$1.6 million recorded in Q2 2025.
  • Rockwell Medical's Income from Continuing Operations' 5-year high stood at $1.7 million during Q3 2024, with a 5-year trough of -$8.9 million in Q4 2021.
  • Its 5-year average for Income from Continuing Operations is -$3.5 million, with a median of -$2.1 million in 2023.
  • Per our database at Business Quant, Rockwell Medical's Income from Continuing Operations surged by 17954.11% in 2024 and then crashed by 63287.67% in 2025.
  • Over the past 5 years, Rockwell Medical's Income from Continuing Operations (Quarter) stood at -$8.9 million in 2021, then surged by 73.59% to -$2.4 million in 2022, then soared by 31.71% to -$1.6 million in 2023, then skyrocketed by 51.7% to -$779000.0 in 2024, then crashed by 132.86% to -$1.8 million in 2025.
  • Its Income from Continuing Operations was -$1.8 million in Q3 2025, compared to -$1.6 million in Q2 2025 and -$1.6 million in Q1 2025.